But now, three GLP-1 medications are FDA-approved specifically for weight loss: liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)
Additionally, TB-500 has been explored for its potential in managing inflammatory conditions and joint injuries , offering hope for individuals suffering from ailments like arthritis or sports-related injuries
Talk with your veterinarian about any concerns so they can recommend what's best for your cat's needs.
Capacity 60 mg Potential benefits Skin-quality research Tissue-repair research Inflammation modulation Angiogenesis & microvascular research Wound-repair research 1
In the era of personalised medicine, it is therefore essential to consider the full range of available therapeutic options and to individualise treatment according to the patients clinical profile
While initially developed for diabetes management, some GLP-1 agonists are also approved for chronic weight management in individuals with obesity or overweight with weight-related health conditions, even if you dont have diabetes